Cas 866002-06-4,4-[(5-cyano-2-methylsulfanyl-pyrimidin-4-ylamino)-methyl]-benzoic acid methyl ester

866002-06-4

Post Buying Request

Basic information

Product Name: 4-[(5-cyano-2-methylsulfanyl-pyrimidin-4-ylamino)-methyl]-benzoic acid methyl ester
Synonyms: 4-[(5-cyano-2-methylsulfanyl-pyrimidin-4-ylamino)-methyl]-benzoic acid methyl ester
CAS NO:866002-06-4
Molecular Formula:
Molecular Weight: 314.368
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-[(5-cyano-2-methylsulfanyl-pyrimidin-4-ylamino)-methyl]-benzoic acid methyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 4-[(5-cyano-2-methylsulfanyl-pyrimidin-4-ylamino)-methyl]-benzoic acid methyl ester(866002-06-4)
EPA Substance Registry System: 4-[(5-cyano-2-methylsulfanyl-pyrimidin-4-ylamino)-methyl]-benzoic acid methyl ester(866002-06-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 866002-06-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

866002-06-4 Suppliers

Recommended suppliers

866002-06-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 866002-06-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,0,0 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 866002-06:
(8*8)+(7*6)+(6*6)+(5*0)+(4*0)+(3*2)+(2*0)+(1*6)=154
154 % 10 = 4
So 866002-06-4 is a valid CAS Registry Number.

866002-06-4Upstream product

866002-06-4Downstream Products

866002-06-4Relevant academic research and scientific papers

INHIBITORS OF HISTONE DEACETYLASE

-

Page/Page column 145, (2010/02/14)

The invention relates to a series of compounds useful for inhibiting histone deacetylase (HDAC) enzymatic activity. The invention also provides a method for inhibiting histone descetylase in a cell using said compounds as well as a method for treating cell proliferative diseases and conditions using said HDAC inhibitors. Further, the invention provides pharmaceutical compositions comprising the HDAC inhibiting compounds and a pharmaceutically acceptable carrier.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 866002-06-4